Indications and uses
For hand sanitizing to decrease bacteria on the skin. Apply topically to the skin to help prevent cross contamination. Recommended for repeated use. Dries in seconds.
For hand sanitizing to decrease bacteria on the skin. Apply topically to the skin to help prevent cross contamination. Recommended for repeated use. Dries in seconds.
Remove lid and discard seal from container Pull wipe from center of roll and thread through opening in lid. Do not push finger through opening. Replace lid, pull wipe up, and the out at 45° angle. The next wipe dispenses automatically Close lid to retain moisture OR Tear V notch on top of plastic bag Pull first wipe from the center of roll through opening of bag Thread first-wipe through the dispensing noozle in l...
Benzalkonium chloride 0.13%
Antiseptic
Keep out of reach of children unless under adult supervision
OR
Water (Aqua), Glycerin, Polysorbate 20, Phenoxyethanol, Sodium Benzoate, Citric Acid, Potassium Sorbate, Fragrance, Ethylhexylglycerin, Decyl Glucoside, Tocopheryl Acetate, Aloe Barbadensis Leaf Juice.
NDC 67151-303-01
WIPES PLUS ®
Re-Order / Item No. 37503
80 CT PRE_MOISTENED TOWELETTES
6.3" X 6.7" (16 cm X 17.01 cm)
NDC 67151-303-04
WIPES PLUS ®
HAND SANITIZING
ALCOHOL FREE WIPES
LEMON SCENT
KILLS 99.9% OF GERMS
240 PRE-MOISTENED TOWELETTES
6' X 6.75' (15.2 cm X 17.1 cm)
PROGRESSIVE PRODUCTS, LLC
4 International Drive, Rye Brook, NY 10573
Call 914-4176022
Re-Order / item No. 33803
NDC 67151-303-07
WIPES PLUS ®
SANITIZING
ALCOHOL FREE WIPES
LEMON SCENT
KILLS 99.9% OF GERMS in 15 SECONDS
800 PRE-MOISTENED TOWELETTES
8" X 6" (20.3 cm X 15.2 cm)
SEE BACK PANEL FOR ADDITONAL PRECAUTIONARY STATEMENTS
NOT A BABY WIPE
PROGRESSIVE PRODUCTS, LLC
4 International Drive, Rye Brook, NY 10573
Call 914-4176022
Re-Order / item No. 33803
NDC 67151-303-08
WIPES PLUS ®
SANITIZING
ALCOHOL FREE WIPES
LEMON SCENT
KILLS 99.9% OF GERMS in 15 SECONDS
1200 PRE-MOISTENED TOWELETTES
8" X 5" (20.32 cm X 12.7 cm)
SEE BACK PANEL FOR ADDITONAL PRECAUTIONARY STATEMENTS
NOT A BABY WIPE
PROGRESSIVE PRODUCTS, LLC
4 International Drive, Rye Brook, NY 10573
Call 914-4176022
Re-Order / item No. 33803
NDC 67151-303-09
WIPES PLUS ®
Re-Order / Item No. 37502
1500 CT
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 67151-303-01 | 2024-01-30 | C162847 | 48780-1 | 1030e365-2991-111a-e063-dadaa90a10e2 | DRUG FACTS |
| 67151-303-04 | 2024-01-30 | C162847 | 48780-1 | 1030e365-2991-111a-e063-dadaa90a10e2 | DRUG FACTS |
| 67151-303-07 | 2024-01-30 | C162847 | 48780-1 | 1030e365-2991-111a-e063-dadaa90a10e2 | DRUG FACTS |
| 67151-303-08 | 2024-01-30 | C162847 | 48780-1 | 1030e365-2991-111a-e063-dadaa90a10e2 | DRUG FACTS |
| 67151-303-09 | 2024-01-30 | C162847 | 48780-1 | 1030e365-2991-111a-e063-dadaa90a10e2 | DRUG FACTS |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67151-303-01 | Wipes Plus | 80 in 1 PACKAGE | SWAB | 80 | 13 | |
| 67151-303-04 | Wipes Plus | 240 in 1 BOTTLE | SWAB | 240 | 13 | |
| 67151-303-07 | Wipes Plus | 800 in 1 BOTTLE | SWAB | 800 | 13 | |
| 67151-303-08 | Wipes Plus | 1200 in 1 BOTTLE | SWAB | 1200 | 13 | |
| 67151-303-09 | Wipes Plus | 1500 in 1 BOTTLE | SWAB | 1500 | 13 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| BENZALKONIUM CHLORIDE | ACTIVE INGREDIENT | F5UM2KM3W7 | 8 | |
| BENZALKONIUM | ACTIVE MOIETY | 7N6JUD5X6Y | 8 | |
| .ALPHA.-TOCOPHEROL ACETATE | INACTIVE INGREDIENT | 9E8X80D2L0 | 8 | |
| ALOE VERA LEAF | INACTIVE INGREDIENT | ZY81Z83H0X | 8 | |
| DISODIUM COCOAMPHODIACETATE | INACTIVE INGREDIENT | 18L9G3U51M | 8 | |
| EDETATE SODIUM | INACTIVE INGREDIENT | MP1J8420LU | 8 | |
| POLYSORBATE 20 | INACTIVE INGREDIENT | 7T1F30V5YH | 8 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | 8 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | 8 | |
| QUATERNIUM-15 | INACTIVE INGREDIENT | E40U03LEM0 | 8 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 8 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 67151-303 | 67151-303-07, 67151-303-01, 67151-303-04, 67151-303-08, 67151-303-09 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| WATER | 059QF0KO0R | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| POLYSORBATE 20 | 7T1F30V5YH | IACT |
| PHENOXYETHANOL | HIE492ZZ3T | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| CITRIC ACID MONOHYDRATE | 2968PHW8QP | IACT |
| POTASSIUM SORBATE | 1VPU26JZZ4 | IACT |
| ETHYLHEXYLGLYCERIN | 147D247K3P | IACT |
| DECYL GLUCOSIDE | Z17H97EA6Y | IACT |
| .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | IACT |
| ALOE VERA LEAF | ZY81Z83H0X | IACT |
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | LOTION / TOPICAL | 0.17 %w/w | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | SOLUTION / TOPICAL | 15 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SPONGE / TOPICAL | 40 %w/w | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | NA | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION, SOLUTION / INTRAVENOUS | 30 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | LOTION / TOPICAL | 2000 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / AURICULAR (OTIC) | 10 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SYRUP / ORAL | 5700 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | PASTE / DENTAL | 0.5 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, DELAYED RELEASE / ORAL | 36 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | SUSPENSION / ORAL | 80 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | EMULSION / TOPICAL | 8 %w/w | ||
| .ALPHA.-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | TABLET / ORAL | 0.5 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, COATED / ORAL | 25 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / ORAL | 27120 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL, METERED / TOPICAL | 1225 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM / BUCCAL | 1.48 mg | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | INJECTION, SOLUTION / INTRAVENOUS | 0.04 %w/v | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | SUSPENSION / OPHTHALMIC | 0.05 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | FILM, EXTENDED RELEASE / TRANSDERMAL | 58.13 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | SOAP / TOPICAL | 0.02 %w/w | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION / ORAL | 1000 mg/15ml | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | GRANULE, FOR SUSPENSION / ORAL | 80 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, FILM COATED / ORAL | 96 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | LIQUID / RESPIRATORY (INHALATION) | 10 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET / ORAL | 64 mg | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | SPONGE / TOPICAL | 0.14 %w/w | ||
| QUATERNIUM-15 | QUATERNIUM-15 | E40U03LEM0 | LOTION / TOPICAL | NA | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SUSPENSION / ORAL | 400 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SPRAY, METERED / NASAL | 0.06 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL / TOPICAL | 19.2 %w/w | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | GEL / TOPICAL | 5 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | SYSTEM / TOPICAL | 4200 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | SUSPENSION / AURICULAR (OTIC) | 0.1 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | LOTION / TOPICAL | 0.2 %w/w | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET / ORAL | 6 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | TABLET, EXTENDED RELEASE / ORAL | 4.2 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION, SOLUTION / INTRAVENOUS | 4000 mg | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | CAPSULE / ORAL | 1 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | POWDER, FOR SUSPENSION / ORAL | 19 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION, SOLUTION / SUBCUTANEOUS | NA | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | SOLUTION / OPHTHALMIC | 0.1 %w/v | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CREAM / TOPICAL | 76000 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | DROPS / ORAL | 200 mg/1ml | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | INJECTION / INTRAVENOUS | 16624 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | EMULSION / OPHTHALMIC | 1.5 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CAPSULE / ORAL | NA | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | CAPSULE / ORAL | 563 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, FOAM / RECTAL | 1214 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | AEROSOL, FOAM / TOPICAL | 8 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, EXTENDED RELEASE / ORAL | 9 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | LOTION, AUGMENTED / TOPICAL | 2070 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE / ORAL | 1072 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | CREAM / VAGINAL | 1225 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / TOPICAL | 5148 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | PASTE / ORAL | 48 mg | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | INJECTION / INTRAMUSCULAR | 0.01 %w/v |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ea255527-c3fe-48b4-e053-2995a90ad016 | 7b74ea7b-9dc0-435e-80ce-8d48b3bef615 | 2022-10-03 | Warnings | ea255527-c3fe-48b4-e053-2995a90ad016 7b74ea7b-9dc0-435e-80ce-8d48b3bef615 |
Adverse event summaries are temporarily unavailable. Other product information remains available.